Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor
Bysanti (Milsaperidone) FDA Approval: What PMHNPs Need to Know
The episode discusses the FDA approval of Bysanti (milsaperidone), a new atypical antipsychotic for schizophrenia and bipolar I. It features a unique dual mechanism aimed at reducing side effects and offers PMHNPs a new prescribing option.